Longbing LING

Dr. Longbing LING


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
JZJianing Zhao
Jianing Zhao
LLLongbing LING
Longbing LING
WZWei Zhu
Wei Zhu
TYTianhao Ying
Tianhao Ying
TYTao Yu
Tao Yu
LZLeiming Zhang
Leiming Zhang

11 April 2022 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
JZJianing Zhao
Jianing Zhao
JRJian Ruan
Jian Ruan
GLGuangyao Lv
Guangyao Lv
QSQi Shan
Qi Shan
ZFZhiping Fan
Zhiping Fan
LLLongbing LING
Longbing LING

24 February 2023 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
SPShengjun Peng
Shengjun Peng
YWYizhou Wang
Yizhou Wang
ZSZhifang Sun
Zhifang Sun
LZLaien Zhao
Laien Zhao
YHYanmei Huang
Yanmei Huang
ZZZhuhong Zhang
Zhuhong Zhang

1 November 2021 in Nanoscale
Verified
Journal Article
Closed access
PDF file
YSYanqin Song
Yanqin Song
MIMuhammad Ismail
Muhammad Ismail
QSQi Shan
Qi Shan
JZJianing Zhao
Jianing Zhao
YZYanping Zhu
Yanping Zhu
LLLongbing LING
Longbing LING
ROS-mediated liposomal dexamethasone with an FA target, termed Dex@FA-ROS-Lips, is fabricated and applied to combat rheumatoid arthritis via inhibiting iRhom2/TNF-α/BAFF pathways.

1 October 2019 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
Zhi WangZhi Wang
Zhi Wang
LLLongbing LING
Longbing LING
QXQing Xia
Qing Xia
XLXinsong Li
Xinsong Li

5 June 2020 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
LLLongbing LING
Longbing LING
HYHaizhou Yu
Haizhou Yu
MIMuhammad Ismail
Muhammad Ismail
YZYanping Zhu
Yanping Zhu
YDYuan Du
Yuan Du
JQJunhui Qi
Junhui Qi
A liposomal platform self-assembled from a novel and universal synthetic dimeric-drug phospholipid.